IL90391A0 - Peptides suppressing the function of the immune system,their preparation and pharmaceutical compositions containing them - Google Patents
Peptides suppressing the function of the immune system,their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL90391A0 IL90391A0 IL90391A IL9039189A IL90391A0 IL 90391 A0 IL90391 A0 IL 90391A0 IL 90391 A IL90391 A IL 90391A IL 9039189 A IL9039189 A IL 9039189A IL 90391 A0 IL90391 A0 IL 90391A0
- Authority
- IL
- Israel
- Prior art keywords
- immune system
- preparation
- function
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 210000000987 immune system Anatomy 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
- C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Transplantation (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU883037A HU201095B (en) | 1988-06-14 | 1988-06-14 | New peptides inhibiting the activity of the immune system and pharmaceutical compositions comprising same, as well as process for producing these peptides and compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
IL90391A0 true IL90391A0 (en) | 1990-01-18 |
Family
ID=10962229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL90391A IL90391A0 (en) | 1988-06-14 | 1989-05-23 | Peptides suppressing the function of the immune system,their preparation and pharmaceutical compositions containing them |
Country Status (13)
Country | Link |
---|---|
US (1) | US5008246A (ja) |
EP (1) | EP0348086B1 (ja) |
JP (1) | JPH0778075B2 (ja) |
CN (1) | CN1038817A (ja) |
AT (1) | ATE119914T1 (ja) |
AU (1) | AU620406B2 (ja) |
CA (1) | CA1327867C (ja) |
DE (1) | DE68921674T2 (ja) |
DK (1) | DK288789A (ja) |
ES (1) | ES2068893T3 (ja) |
GR (1) | GR3015890T3 (ja) |
HU (1) | HU201095B (ja) |
IL (1) | IL90391A0 (ja) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990003180A1 (en) * | 1988-09-30 | 1990-04-05 | Immunobiology Research Institute, Inc. | Peptides having t cell suppressor activity |
EP0445606B1 (en) * | 1990-02-27 | 1997-01-22 | The Agency of Industrial Science and Technology | Novel oligopeptides, pharmaceutical composition and food containing the same, and use of oligopeptides |
US6077823A (en) * | 1991-03-11 | 2000-06-20 | Creative Biomolecules, Inc. | Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury |
US6194376B1 (en) | 1991-03-11 | 2001-02-27 | Creative Biomolecules, Inc. | Method for modulating inflammatory response comprising administering morphogen |
JP3973050B2 (ja) | 1992-09-16 | 2007-09-05 | キュリス,インコーポレイテッド | モルフォゲン誘発性肝再生 |
US5639729A (en) * | 1993-08-26 | 1997-06-17 | Immunobiology Research Institute, Inc. | Tripeptides useful in immune and CNS therapy |
RU2107691C1 (ru) | 1995-03-02 | 1998-03-27 | Дейгин Владислав Исакович | Пептид и способ его получения |
US6159940A (en) * | 1996-02-28 | 2000-12-12 | Immunotech Developments Inc. | Method for modulating hemopoiesis |
CA2249596C (en) | 1996-03-22 | 2011-11-08 | Creative Biomolecules, Inc. | Methods for enhancing functional recovery following central nervous system ischemia or trauma |
AU735592B2 (en) * | 1997-05-17 | 2001-07-12 | Biogen Idec Ma Inc. | Use of a CD40:CD154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection |
EP1754490A3 (en) | 1997-06-20 | 2010-01-20 | Biogen Idec MA Inc. | CD 154 blockage therapy for pancreatic islet tissue transplantation in primates |
CN1927879B (zh) * | 2006-09-25 | 2010-11-24 | 吉林大学 | 胸腺五肽活性异构体及其在药物制备中的应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU185263B (en) * | 1981-06-12 | 1984-12-28 | Richter Gedeon Vegyeszet | Process for producing peptides effective on the immuncontroll analogous with the tp5 |
US4505853A (en) * | 1983-11-18 | 1985-03-19 | Ortho Pharmaceutical Corporation | Enzyme-resistant immunomodulatory peptides |
EP0215805A1 (en) * | 1985-01-18 | 1987-04-01 | MERCK PATENT GmbH | Immunoregulatory peptides |
NZ229004A (en) * | 1988-05-19 | 1993-09-27 | Immunobiology Res Inst Inc | Tetrapeptides having t cell helper acitivity |
-
1988
- 1988-06-14 HU HU883037A patent/HU201095B/hu not_active IP Right Cessation
-
1989
- 1989-05-23 IL IL90391A patent/IL90391A0/xx unknown
- 1989-06-12 CN CN89103990A patent/CN1038817A/zh active Pending
- 1989-06-13 ES ES89305931T patent/ES2068893T3/es not_active Expired - Lifetime
- 1989-06-13 AU AU36293/89A patent/AU620406B2/en not_active Ceased
- 1989-06-13 US US07/365,457 patent/US5008246A/en not_active Expired - Fee Related
- 1989-06-13 DE DE68921674T patent/DE68921674T2/de not_active Expired - Fee Related
- 1989-06-13 AT AT89305931T patent/ATE119914T1/de not_active IP Right Cessation
- 1989-06-13 DK DK288789A patent/DK288789A/da not_active Application Discontinuation
- 1989-06-13 JP JP1148522A patent/JPH0778075B2/ja not_active Expired - Lifetime
- 1989-06-13 CA CA000602643A patent/CA1327867C/en not_active Expired - Fee Related
- 1989-06-13 EP EP89305931A patent/EP0348086B1/en not_active Expired - Lifetime
-
1995
- 1995-04-19 GR GR950401027T patent/GR3015890T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
ES2068893T3 (es) | 1995-05-01 |
HUT50195A (en) | 1989-12-28 |
EP0348086B1 (en) | 1995-03-15 |
US5008246A (en) | 1991-04-16 |
DE68921674D1 (de) | 1995-04-20 |
CA1327867C (en) | 1994-03-15 |
DK288789D0 (da) | 1989-06-13 |
EP0348086A2 (en) | 1989-12-27 |
HU201095B (en) | 1990-09-28 |
JPH0232095A (ja) | 1990-02-01 |
GR3015890T3 (en) | 1995-07-31 |
ATE119914T1 (de) | 1995-04-15 |
EP0348086A3 (en) | 1990-09-12 |
AU620406B2 (en) | 1992-02-20 |
DK288789A (da) | 1989-12-15 |
AU3629389A (en) | 1990-01-04 |
JPH0778075B2 (ja) | 1995-08-23 |
DE68921674T2 (de) | 1995-08-03 |
CN1038817A (zh) | 1990-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1153265B (it) | Polipeptidi contenenti la sequenza degli amminoacidi dell'interferone umano immune (interferone umano gamma), relativi veicoli di espressione, loro procedimento di preparazione, composizioni farmaceutiche contenenti tali polipeptidi | |
EP0662827A4 (en) | THERAPEUTIC AND DIAGNOSTIC METHODS AND COMPOSITIONS BASED ON NOTCH PROTEINS AND NUCLEIC ACIDS. | |
ES8801674A1 (es) | Un procedimiento para la preparacion de una proteina que presenta actividad procoagulante. | |
AU6819294A (en) | Oral drug delivery compositions and methods | |
EP0210189A4 (en) | RECOMBINANT ALVEOLAR SURFACE ACTIVE PROTEIN. | |
DE3873397D1 (de) | Bifunktionelle proteine. | |
IL90391A0 (en) | Peptides suppressing the function of the immune system,their preparation and pharmaceutical compositions containing them | |
CA2042016A1 (en) | Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis | |
HUT66309A (en) | Bpc peptides, their preparation and therapeutic use | |
IL80562A0 (en) | Recombinant human lysozyme,its preparation by recombinant dna technology and pharmaceutical compositions containing it | |
IL90356A0 (en) | Amphiphilic peptides and pharmaceutical compositions containing them | |
FI93843C (fi) | Menetelmä angiogeenisen tekijän tuottamiseksi | |
IE890087L (en) | Recombinant human interleukin-1 alpha polypeptides | |
CA2089111A1 (en) | Smooth muscle mitogen and isolated dna coding therefor | |
EP0723016A3 (en) | Leukocyte activation factor | |
EP0342015A3 (en) | Peptides, their use and pharmaceutical compositions containing them | |
IL96513A (en) | Dna encoding for a polypeptide comprising the amino acid sequence of des-cys-tyr-cys recombinant human immune interferon,producing such a polypeptide and pharmaceutical compositions comprising it | |
CA2311684A1 (en) | Chemically-modified g-csf |